Research Tools

Mammoth Biosciences

Brief Description

Mammoth’s vision is to provide a CRISPR-based platform on which an infinite number of tests can be built by both ourselves and our partners - democratizing access to an endless variety of tests for bio sensing in healthcare, as well as across industries such as agriculture, manufacturing, forensics, and more.

Timeline 2017. Company founded Inventors

Jennifer Doudna, Alexandra Seletsky, Amanda Mok, Brittney Wai-Li Thornton, David Frank Savage, Dylan Smock, Eli Dugan, Emeric Jean Charles, Gavin Knott, James Doudna Cate, John Desmarais, Liana Lareau,...

Microreactor Technologies

Brief Description

Developer of miniature bioreactor technology platforms. The company offers improved cell fermentation and cultivation productivity services. It develops and operates Micro-24, fermentation and cell culture system which runs up to 24 simultaneous experiments with independent control of each reactor's gas supply, temperature, and pH.

Microreactor Technologies, Inc. was acquired by Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, in 2010.

Timeline 2003. Company founded 2010. Company...

Cell Guidance Systems Ltd

Brief Description

Cell Guidance Systems is based in Cambridge (UK), at the heart of one of the world's most exciting biotech regions. The company develops therapeutic products as well as medical research tools and technologies that expand the possibilities of life science research and medicine. The company's success has been achieved by working closely with many researchers from around the world (including Japan, USA, Netherlands, Italy, Singapore, and the UK) to develop truly innovative products that address unmet medical and research needs. Many of the Cell...

Lumiphore, Inc.

Brief Description

Lumiphore develops proprietary bi-functional chelators for biomedical applications in drug discovery research, diagnostics, and therapeutics. These include biological detection systems based on luminescent lanthanide complexes (which provide a unique combination of sensitivity, reliability, flexibility and high throughput) and radioisotope chelators for attachment to carrier molecules used in cancer therapeutics and radio-imaging diagnostics that can be paired as a companion diagnostics in radio-pharmaceutical therapeutics.

Timeline 2001. Company...

CellASIC Corp.

Brief Description

CellASIC¨ ONIX Microfluidic Platform delivers precise control for live cell analysis experiments by facilitating long-term perfusion cell culture. Cutting-edge microfluidics technology provides an improved cell culture microenvironment, exceptional quality for high magnification microscopy, and superior media switching capabilities.

The company was founded by UC Berkeley Professor of Bioengineering Luke Lee and his graduate students Paul Hung and Philip Lee.

Timeline 2004. Company founded 2012...

Research Tools

Vitrichoric, Inc.

Brief Description

Vitrichoric, Inc. develops technology for high-stability supercooling of aqueous solutions or suspensions for the preservation of biological matter.

Timeline 2021. Company founded Inventors

Gabriel Nastase, Boris Rubinsky, Gideon Ukpai

BioChoric

Brief Description

Biochoric uses isochoric supercooling to enable stable preservation of sensitive biological matter at sub-zero temperatures without freezing or solidification.

Timeline 2021. Company founded Inventors

Matthew Powell-Palm, Boris Rubinsky

Ventria Biosciences (formerly known as Applied Phytologics Inc.)

Brief Description

Ventria Bioscience is a privately held biopharmaceutical company with a product pipeline enabled by ExpressTec. ExpressTec is a patented, plant-based recombinant protein manufacturing technology that delivers a ten-fold higher recombinant protein yield than other plant-based systems. Ventria Bioscience's platform technology delivers meaningful and sustainable economic advantages by enabling new product opportunities that were not previously available. It can be used to develop new biotherapeutics, novel vaccines, reagents for biomanufacturing, and industrial and biofuel...

Vedere Bio II

Brief Description

Vedere Bio II is pioneering beyond traditional gene therapy to not just slow vision loss from inherited retinal degenerations (IRDs) or dry age-related macular degeneration (dry AMD) with geographic atrophy (GA), but actually restore it.

Timeline 2021. Vedere Bio II launches as the successor to the first Vedere Bio, which was acquired by Novartis in September 2020 Inventors

Matthew Banghart, Michael Hayden Berry, Katherine Borges, Johannes Broichhagen, John Flannery, Doris Fortin, Benjamin Gaub, Scott Franklin Geller, Pablo Gorostiza, Karen...